Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02)

Autor: Schmitz, S., Kaminsky-Forrett, M.-C., Henry, S., Zanetta, S., Geoffrois, L., Bompas, E., Moxhon, A., Mignion, L., Guigay, J., Knoops, L., Hamoir, M., Machiels, J.-P. *
Zdroj: In Annals of Oncology August 2012 23(8):2153-2161
Databáze: ScienceDirect